At the completion of this activity, the participant will be able to:
1. Review the background and prevalence of adulterants in the illicit drug supply
2. Explain the pharmacologic properties of medetomidine
3. Outline case reports regarding medetomidine-related overdose and withdrawal
4. Discuss pharmacologic management of overdose and withdrawal involving medetomidine

Session date: 
11/03/2025 - 1:00pm to 2:00pm EST
Location: 
AGH Lecture Hall (1st Floor South Tower) & Zoom Webinar
To Join the Zoom Webinar: https://highmarkhealth.zoom.us/j/98672570454?pwd=VU80YWJYNjgraGVsQ0xkU2xSNWozQT09
Meeting ID: 986 7257 0454; Passcode: 877628
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Please login or register to take this course.